- Previous Close
0.0550 - Open
0.0550 - Bid 0.0450 x --
- Ask 0.0750 x --
- Day's Range
0.0550 - 0.0550 - 52 Week Range
0.0500 - 0.2200 - Volume
29,000 - Avg. Volume
38,427 - Market Cap (intraday)
3.124M - Beta (5Y Monthly) 1.87
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Dec 30, 2024 - Jan 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
izocorp.comRecent News: IZO.CN
View MorePerformance Overview: IZO.CN
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IZO.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IZO.CN
View MoreValuation Measures
Market Cap
3.12M
Enterprise Value
5.07M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-412.72%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.35M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
102.05k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-716.77k